A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X, Zhi X, Yang Z, Tian H, Li Y, Li M, Zhao W, Zhang C, Wang T, Liu J, Shen D, Zheng C, Zhao D, Yang S, Qi J, Xin H, Stojadinovic A, Avital I, Lee LJ, Rao J, Zhang W.
Wang X, et al. Among authors: zhao w, zhao d.
Oncotarget. 2017 Jul 11;8(28):45345-45355. doi: 10.18632/oncotarget.17477.
Oncotarget. 2017.
PMID: 28514755
Free PMC article.